Anbio Biotechnology Class...

NASDAQ: NNNN · Real-Time Price · USD
51.50
1.36 (2.71%)
At close: Aug 15, 2025, 2:51 PM

Anbio Biotechnology Class A Ordinary Shares Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023
Net Income
-1.32M 3.89M 792.93K 1.64M
Depreciation & Amortization
n/a n/a 3.54K 9.49K
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-1.94M 236.67K -1.45M 394.13K
Other Non-Cash Items
-209.64K -149.34K -157.43K -17.68K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
3.14M -3.09M -1.97M 668.35K
Operating Cash Flow
1.6M 647.54K -1.33M 2.3M
Capital Expenditures
-1.67 0.31 -0.84 0.56
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-11.36M -27.03M -20.06M n/a
Sales Maturities Of Investments
11.58M 27.18M 20.22M 1.71M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
215.57K 149.34K 160.7K 1.71M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
-248.89K -124.14K 230.08K -276.41K
Net Cash Flow
n/a n/a n/a n/a
Free Cash Flow
1.6M 647.54K -1.33M 2.3M